Navigation Links
Perrigo Announces FDA Final Approval for Miconazole
Date:6/3/2010

xn-location">the United States, Australia, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections.  While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 27, 2009, as well as the Company's subsequent filings with the Securities and Exchange Commi
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Acquires Rights to Generic Version of HalfLytely® from Novel Laboratories
2. Perrigo Company to Present at the Citi Investment Research Global Health Care Conference
3. Perrigo Company Announces Quarterly Dividend
4. Perrigo Acquires Infant Formula Manufacturer PBM Holdings for $808 Million
5. Perrigo Company Announces Quarterly Dividend
6. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
7. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
8. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
9. Perrigo Company To Present at the Sidoti Emerging Growth Conference
10. Perrigo Company Announces Dividend Increase
11. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... today they are expanding their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 ...
(Date:6/2/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached an agreement to settle ... Delaware Court of Chancery, which names as ... directors and officers, and names the Company as a ... re CytRx Corp. Stockholder Derivative Litigation , C.A. No. ...
(Date:6/2/2015)... ACTON, Mass. , June 2, 2015  Psychemedics ... global leader for over twenty-five years, announced the addition ... panels. In response to growing abuse concerns, the addition ... panel and D-Amphetamine/Adderall® was added as an option to ... , Chairman and CEO stated:  "Sadly, more and more ...
Breaking Medicine Technology:Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3
... Inc. (Nasdaq: BNVI ) announced today that it ... year 2010 ended September 30, 2010 on Thursday, November 11, ... to review the financial results on Thursday, November 11, 2010 ... the call by dialing (877) 317-6789 or (412) 317-6789, or ...
... 4, 2010 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... Brian M. Culley, will present at the Wall Street Analyst ... 2010 at 12:50 p.m. Eastern time, at The University Club ... a live audio webcast and slide presentation on the Company,s ...
Cached Medicine Technology:
(Date:6/2/2015)... Branchburg, NJ (PRWEB) June 02, 2015 ... independent verification for non-GMO products made according to ... avoidance. Verified products are produced in compliance with ... testing of all GMO risk ingredients, facility inspections ... possible standards for GMO avoidance. , “Savoury Systems ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Consumer ... consumer organization, today announced its commitment to help ... to the use of antibiotics sicken about 2.25 ... to the Centers for Disease Control and Prevention. ... President and CEO Marta Tellado participating in the ...
(Date:6/2/2015)... June 02, 2015 Robert LaPrade, ... Officer at the Steadman Philippon Research Institute, participated in ... for Single Sport Specialization? ” This was a collaborative ... (AOSSM) Research Committee that was recently published in the ... this project was limited, there is evidence that early ...
(Date:6/2/2015)... While the movie box office may be ... books themselves are stepping into a new role: that ... produce educational comics in multiple languages that will explain ... - an international effort to address humanity’s most pressing ... energy, inequality, climate change and more. , “The United ...
(Date:6/2/2015)... North Vancouver, B.C., Canada (PRWEB) June 02, 2015 ... American publisher of audit, compliance and risk ... of a new online risk management effectiveness gap-improvement ... reduce the effect of uncertainty on objectives. Organizations ... but they improve their capabilities to do this ...
Breaking Medicine News(10 mins):Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 2Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 3Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4
... Quarter Revenue of $74.6 Million - , ... Guidance -Fourth Quarter and Full Year 2008 Highlights:- Fourth quarter ... quarter 2007- Full year 2008 total revenue of $250.1 million; ... the second half 2008 of $10 million; exceeds prior guidance ...
... All, Will Solve Crisis and Cut Costs OAKLAND, Calif., ... nurses today praised President Obama,s call for "comprehensive" healthcare ... emphasized that only genuine reform, as in expanding Medicare ... and rein in the skyrocketing costs that the president ...
... Feb. 25 Medarex, Inc. (Nasdaq: MEDX ) ... ended December 31, 2008. Medarex,s net loss for the year ... share, as compared to a net loss of $27.1 million, ... 2008 includes a gain of $151.8 million, or $1.18 per ...
... , , WEDNESDAY, Feb. 25 (HealthDay News) -- U.S. ... drug applications from a Ranbaxy Laboratories plant in India ... Ranbaxy, based in India, is one of the largest ... , "We took this action after it became apparent ...
... of Craneware,s 10th Anniversary YearATLANTA, Feb. 25 Craneware (AIM: CRW.L), ... health systems, is pleased to announce its interim results for the ... , Total of $21.8m ... 28% ...
... Ranbaxy has just received a letter and information ... Paonta Sahib facility have been added to a list ... "AIP". Ranbaxy will analyze the letter and other ... FDA has said it has no evidence the drugs ...
Cached Medicine News:Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 8Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 9Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 10Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 11Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 12Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 13Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 14Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 15Health News:Nurses Welcome President's Call for Comprehensive Health Reform 2Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 2Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 3Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 4Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 5Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 6Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 7Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 8Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 9Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 10Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 11Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 12Health News:FDA Halts New Applications From Indian Drug Maker's Plant 2Health News:Craneware Announces Half-Year Results 2Health News:Press Statement Issued by Ranbaxy Laboratories Limited 2
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... tubes contain a buffered sodium ... with a citrate concentration of ... mol/l (3.8%). The mixing ratio ... to 9 parts blood. In ...
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: